Mobilized colistin-resistant gene (MCR-1) in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli in Abuja, Nigeria.
7 affiliations
- 1Department of Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria, Nigeria.
- 2Department of Microbiology, Federal Medical Centre, Jalingo, Taraba State, Nigeria.
- 3Department of Pharmacy, Federal Medical Centre, Jalingo, Taraba State, Nigeria.
- 4Department of Planning, Research and Statistics, Nigeria Centre for Disease Control and Prevention (NCDC), HQ Office, Abuja, Nigeria.
- 5Health Research Division: Golden Bricks Inc., Nigeria.
- 6The Management, Federal Medical Centre, Jalingo, Taraba State, Nigeria.
- 7Department of Medical Microbiology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria.
Abstract
Introduction
The global increase in reports of transferable colistin resistance has become a significant public health concern. In Nigeria, only a limited number of studies have documented the presence of mobilized colistin resistance genes (MCR) in isolates derived from both human and animal sources.Aim
This investigation aimed to detect the presence of the mobilized colistin-resistant gene (MCR-1) in multiple drug-resistant, extended-spectrum beta-lactamase-producing clinical isolates of Escherichia (E.) coli and Klebsiella (K.) pneumoniae obtained from selected hospitals in Abuja, Nigeria.Materials and method
A total of 115 consecutive, non-duplicate presumptive clinical isolates of E. coli and K. pneumoniae were collected over three months from two hospitals in Abuja: Garki Hospital Abuja and Nisa Hospital Abuja. These isolates were identified employing rapid identification kits. Antimicrobial susceptibility testing was conducted using the agar disc diffusion method, while phenotypic detection of ESBLs was performed via double-disc synergy tests. The MIC of colistin was determined using the broth microdilution method. Molecular characterization of the ESBL and MCR-1 genes was achieved through PCR analysis.Results
Out of 115 clinical isolates, 49 (42.6%) were identified as E. coli and K. pneumoniae, with 36 (73.5%) of these being multidrug-resistant (MDR). Among the MDR isolates, 15 demonstrated phenotypic resistance to third-generation cephalosporins (primary indicators for TEM and SHV-derived ESBLs), e.g., cefpodoxime. These 15 isolates were selected for ESBL screening. Seven isolates tested positive and were subsequently subjected to double-disc synergy testing. Notably, five out of these seven isolates were confirmed as phenotypic ESBL producers. The result of PCR analysis revealed that 3/5 harbored multiple ESBL genes; E. coli harbored blaSHV and blaCTX-M or blaSHV and blaTEM, K. penumoniae harbored blaSHV, blaTEM, and blaCTX-M. None of the investigated isolates harbored the blaOXA gene. A total of 8 isolates comprising the 3 genotypic ESBL-positive isolates, the 2 phenotypic colistin-resistant isolates, and 3 borderline phenotypic colistin-resistant isolates were molecularly analyzed to detect MCR-1 genes. One out of /8 isolates of E. coli isolated from a patient's urine sample harbored the MCR-1 gene.Conclusion
This study is, to the best of our knowledge, the first report of MCR-1 gene detection from a human clinical sample in Abuja, the capital city of Nigeria. The increasing emergence of mobilized colistin resistance genes in isolates of clinical significance as such, calls for an urgent need to preserve the efficacy of our last resort antibiotics through the institutionalization and adequate implementation of antibiotic stewardship.
Related
- When the Antibiogram Offers Nothing Else: Ceftriaxone–Sulbactam–Disodium EDTA With Intravenous Colistin in Two Neonates With Metallo‐β‐Lactamase‐Producing Acinetobacter baumannii Meningitis
- Phenotypic and molecular characterization of extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae isolates from communities in South Western Uganda
- Distribution of blaCTX-M, blaTEM and blaSHV encoding-genes among extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates at the different hospitals in Tabuk, Kingdom of Saudi Arabia
- Effects of a community-based intervention bundle on household transmission of extended spectrum β-lactamase-producing Escherichia coli in rural Burkina Faso to target community-level drivers of antimicrobial resistance in sub-Saharan Africa: a cluster-randomised trial
- Antimicrobial-resistant Salmonella and Escherichia coli in fresh vegetables from Ouagadougou, Burkina Faso: Prevalence, β-lactamase genes, and food safety implications
BibTeX
@article{abdullahi2026mobilized,
title = {{Mobilized colistin-resistant gene (MCR-1) in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli in Abuja, Nigeria.}},
author = {Muhammad Abdullahi and Aisha Shehu Adamu and Lawan Adamu and Rebecca Olajumoke Bolaji and Jimoh Olanrewaju and Busayo Olalekan Olayinka},
journal = {GMS hygiene and infection control},
year = {2026},
month = sep,
doi = {10.3205/dgkh000671},
url = {https://europepmc.org/article/MED/42923516},
note = {CC BY},
}
RIS
TY - JOUR
TI - Mobilized colistin-resistant gene (MCR-1) in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli in Abuja, Nigeria.
AU - Muhammad Abdullahi
AU - Aisha Shehu Adamu
AU - Lawan Adamu
AU - Rebecca Olajumoke Bolaji
AU - Jimoh Olanrewaju
AU - Busayo Olalekan Olayinka
PY - 2026
DA - 2026/09/01
JO - GMS hygiene and infection control
DO - 10.3205/dgkh000671
UR - https://europepmc.org/article/MED/42923516
AB - Introduction The global increase in reports of transferable colistin resistance has become a significant public health concern. In Nigeria, only a limited number of studies have documented the presence of mobilized colistin resistance genes (MCR) in isolates derived from both human and animal sources.Aim This investigation aimed to detect the presence of the mobilized colistin-resistant gene (MCR-1) in multiple drug-resistant, extended-spectrum beta-lactamase-producing clinical isolates of Escherichia (E.) coli and Klebsiella (K.) pneumoniae obtained from selected hospitals in Abuja, Nigeria.Materials and method A total of 115 consecutive, non-duplicate presumptive clinical isolates of E. coli and K. pneumoniae were collected over three months from two hospitals in Abuja: Garki Hospital Abuja and Nisa Hospital Abuja. These isolates were identified employing rapid identification kits. Antimicrobial susceptibility testing was conducted using the agar disc diffusion method, while phenotypic detection of ESBLs was performed via double-disc synergy tests. The MIC of colistin was determined using the broth microdilution method. Molecular characterization of the ESBL and MCR-1 genes was achieved through PCR analysis.Results Out of 115 clinical isolates, 49 (42.6%) were identified as E. coli and K. pneumoniae, with 36 (73.5%) of these being multidrug-resistant (MDR). Among the MDR isolates, 15 demonstrated phenotypic resistance to third-generation cephalosporins (primary indicators for TEM and SHV-derived ESBLs), e.g., cefpodoxime. These 15 isolates were selected for ESBL screening. Seven isolates tested positive and were subsequently subjected to double-disc synergy testing. Notably, five out of these seven isolates were confirmed as phenotypic ESBL producers. The result of PCR analysis revealed that 3/5 harbored multiple ESBL genes; E. coli harbored blaSHV and blaCTX-M or blaSHV and blaTEM, K. penumoniae harbored blaSHV, blaTEM, and blaCTX-M. None of the investigated isolates harbored the blaOXA gene. A total of 8 isolates comprising the 3 genotypic ESBL-positive isolates, the 2 phenotypic colistin-resistant isolates, and 3 borderline phenotypic colistin-resistant isolates were molecularly analyzed to detect MCR-1 genes. One out of /8 isolates of E. coli isolated from a patient's urine sample harbored the MCR-1 gene.Conclusion This study is, to the best of our knowledge, the first report of MCR-1 gene detection from a human clinical sample in Abuja, the capital city of Nigeria. The increasing emergence of mobilized colistin resistance genes in isolates of clinical significance as such, calls for an urgent need to preserve the efficacy of our last resort antibiotics through the institutionalization and adequate implementation of antibiotic stewardship.
SN - 2196-5226
ER -